Tag Archives: DNA

Re-analysis of genetic risks for CFS from 23andMe data finds few remain

Posted on 04/21/2021 by wames

Re-analysis of genetic risks for Chronic Fatigue Syndrome from 23andMe data finds few remain, by Felice L Bedford, Bastian Greshake Tzovaras in medRxiv 2020.10.27.20220939  [doi.org/10.1101/2020.10.27.20220939] Data from 23andMe had been compared with a control database that was found to contain … Continue reading →

Posted in News | Tagged , , , | Comments Off on Re-analysis of genetic risks for CFS from 23andMe data finds few remain

SNPs in CFS/ME genes could lead to diagnostic test for CFS/ME subtypes

Posted on 09/24/2014 by wames

Research abstract Aims We have reported gene expression changes in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and the fact that such gene expression data can be used to identify subtypes of CFS/ME with distinct clinical phenotypes. Due to the … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on SNPs in CFS/ME genes could lead to diagnostic test for CFS/ME subtypes

The importance of understanding how our genes change

Posted on 08/28/2014 by wames

Extract from article by Cort Johnson: Epigenetics refers to the changes in sites in our DNA that are susceptible to change over time which can modify the expression of our genes.  Our genetic heritage, it turns out, only sets the … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on The importance of understanding how our genes change

DNA methylation modifications in CFS

Posted on 08/27/2014 by wames

Abstract Chronic Fatigue Syndrome (CFS), also known as myalgic encephalomyelitis, is a complex multifactorial disease that is characterized by the persistent presence of fatigue and other particular symptoms for a minimum of 6 months. Symptoms fail to dissipate after sufficient … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on DNA methylation modifications in CFS